Advanced

Comorbidity in rheumatoid arthritis

Turesson, Carl LU (2016) In Swiss Medical Weekly 146.
Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory condition, which is associated with an increased risk of comorbidity from other diseases. RA disease severity is a major predictor of development of cardiovascular disease, serious infections and malignant lymphoma. This reflects the role of chronic inflammation in the underlying pathology. Recent surveys indicate that although clinical outcomes have improved in patients with RA, mainly owing to access to more efficient pharmacotherapy, comorbidity remains a major issue in many patients. Register-based observational studies are useful sources of information on the impact of comorbidity and the efficacy and safety of antirheumatic treatment in patients with coexisting diseases. As a... (More)

Rheumatoid arthritis (RA) is a chronic inflammatory condition, which is associated with an increased risk of comorbidity from other diseases. RA disease severity is a major predictor of development of cardiovascular disease, serious infections and malignant lymphoma. This reflects the role of chronic inflammation in the underlying pathology. Recent surveys indicate that although clinical outcomes have improved in patients with RA, mainly owing to access to more efficient pharmacotherapy, comorbidity remains a major issue in many patients. Register-based observational studies are useful sources of information on the impact of comorbidity and the efficacy and safety of antirheumatic treatment in patients with coexisting diseases. As a part of strategies to improve further the management of patients with RA, multidisciplinary collaboration for prevention and early detection of comorbidities is of major importance.

(Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Swiss Medical Weekly
volume
146
publisher
EMH Swiss Medical Publishers Ltd.
external identifiers
  • scopus:84962399025
ISSN
1424-7860
DOI
10.4414/smw.2016.14290
language
English
LU publication?
yes
id
5ceff67f-1a10-4dfe-8b39-5c58186f1e79
date added to LUP
2016-04-28 12:24:18
date last changed
2017-07-09 04:49:37
@article{5ceff67f-1a10-4dfe-8b39-5c58186f1e79,
  abstract     = {<p>Rheumatoid arthritis (RA) is a chronic inflammatory condition, which is associated with an increased risk of comorbidity from other diseases. RA disease severity is a major predictor of development of cardiovascular disease, serious infections and malignant lymphoma. This reflects the role of chronic inflammation in the underlying pathology. Recent surveys indicate that although clinical outcomes have improved in patients with RA, mainly owing to access to more efficient pharmacotherapy, comorbidity remains a major issue in many patients. Register-based observational studies are useful sources of information on the impact of comorbidity and the efficacy and safety of antirheumatic treatment in patients with coexisting diseases. As a part of strategies to improve further the management of patients with RA, multidisciplinary collaboration for prevention and early detection of comorbidities is of major importance.</p>},
  articleno    = {w14290},
  author       = {Turesson, Carl},
  issn         = {1424-7860},
  language     = {eng},
  publisher    = {EMH Swiss Medical Publishers Ltd.},
  series       = {Swiss Medical Weekly},
  title        = {Comorbidity in rheumatoid arthritis},
  url          = {http://dx.doi.org/10.4414/smw.2016.14290},
  volume       = {146},
  year         = {2016},
}